In this video interview, Michael Andreini, president and CEO of the Multiple Myeloma Research Foundation, discusses how MMRF ...
Recent survey study of 978 cancer patients and their relatives uncovered reasons behind their willingness, or lack thereof, ...
The Phase III HYPERION trial was stopped early after strong positive interim results from the ZENITH trial demonstrated the efficacy of Winrevair (sotatercept-csrk) in treating pulmonary arterial ...
In this video interview, Michael Andreini, president and CEO of the Multiple Myeloma Research Foundation, talks unmet need in ...
Research from the Tufts Center for the Study of Drug Development’s PACT Consortium shows DCTs encourage higher participation ...
In this video interview, Michael Andreini, president and CEO of the Multiple Myeloma Research Foundation, highlights the ...
In year two of the trial, Elevidys demonstrated statistically significant and clinically improvements across three key ...
Initiatives to Establish Capabilities in Early Phase Clinical Research in Malaysia ...
Initiatives to Establish Capabilities in Early Phase Clinical Research in Malaysia ...
Initiatives to Establish Capabilities in Early Phase Clinical Research in Malaysia ...
Initiatives to Establish Capabilities in Early Phase Clinical Research in Malaysia ...
Initiatives to Establish Capabilities in Early Phase Clinical Research in Malaysia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback